Drug intelligence / Profile preview

Neossance Squalane

Development stage
Unknown
Lead developer
Amyris
Modality
Small Molecules
Administration
Topical
01

Overview

Neossance Squalane is a high-purity, sustainably sourced emollient produced through the fermentation of sugarcane using proprietary yeast strains. Originally developed by Amyris and now part of the Givaudan portfolio, it serves as a renewable, high-performance alternative to squalane derived from shark liver oil or olives. Chemically, it is a saturated C30 hydrocarbon (2,6,10,15,19,23-hexamethyltetracosane) that is identical to the squalane naturally found in human sebum. Its primary mechanism of action is the restoration of the skin's lipid barrier, where it acts as an occlusive to prevent transepidermal water loss (TEWL) and as an emollient to soften and soothe the skin. It is highly stable, non-comedogenic, and widely used in topical dermatological and cosmetic formulations to treat dry skin conditions and improve overall skin health.

Brand names
Neossance Squalane
Other names
squalanesugarcane squalane2,6,10,15,19,23-hexamethyltetracosane

Beyond the preview

Go deeper on Neossance Squalane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neossance Squalane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call